about
Next generation of weight management medications: implications for diabetes and CVD riskGut hormones and the regulation of energy homeostasisAnti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanismCodonopsis lanceolata extract prevents diet-induced obesity in C57BL/6 miceThe role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agentsFermented Rhizoma Atractylodis Macrocephalae alleviates high fat diet-induced obesity in association with regulation of intestinal permeability and microbiota in rats.Using personality as a predictor of diet induced weight loss and weight management.Antiobesity Effects of Unripe Rubus coreanus Miquel and Its Constituents: An In Vitro and In Vivo Characterization of the Underlying Mechanism.Pharmacotherapeutic options for overweight adolescents.Modulation of neuropeptide Y receptors for the treatment of obesity.Functional foods as potential therapeutic options for metabolic syndrome.Interruptin B induces brown adipocyte differentiation and glucose consumption in adipose-derived stem cells.Evidence of complex involvement of serotonergic genes with restrictive and binge purge subtypes of anorexia nervosa.An evaluation of the genotoxic and cytotoxic effects of the anti-obesity drugs sibutramine and fenproporex.Effects of acute and chronic administration of fenproporex on DNA damage parameters in young and adult rats.Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine.
P2860
Q28082858-1C5E5C88-EC6E-48BB-8D57-D58BD3F07732Q28278826-ACE34AD0-1157-42CC-A830-AA18F8E7C815Q33931073-BCF8CFF8-AA24-4F78-9389-722E233E674EQ34577937-41884EA5-C90A-45C2-BCD9-EFE84903B355Q34620531-C1AE0083-119C-4DDF-A1CA-7B14BE5C4FC1Q35086718-F7EB2A4B-4CAD-4EA6-ADE8-7BB8880AAA4DQ35618219-26974766-1750-4002-9A23-357B14F0243AQ36556246-AFEA350A-9131-44D2-A5DF-E5E73945A72BQ36891391-DA1CCBF7-C542-402D-8A32-0CD43F028B6BQ37594773-4A49582D-7396-4AC8-9341-039FE1B010A0Q38582214-677FADE4-C444-48E5-BCA8-91FC48787501Q38651575-7F1E00F7-90FF-4E41-AFCB-65E89C465899Q43025657-14369497-6905-4831-9599-573FBD975762Q43201843-C9FBD826-09AC-439D-A3DD-CA85C30E54C8Q44739272-F306F11C-E1C0-49F9-AE96-CB032B8C25DAQ46637829-F1B8F0DA-F2CE-4EA0-BE26-8C5D1FC9003E
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Pharmacotherapy for obesity.
@ast
Pharmacotherapy for obesity.
@en
type
label
Pharmacotherapy for obesity.
@ast
Pharmacotherapy for obesity.
@en
prefLabel
Pharmacotherapy for obesity.
@ast
Pharmacotherapy for obesity.
@en
P1433
P1476
Pharmacotherapy for obesity.
@en
P2093
Jason C G Halford
P356
10.1016/J.APPET.2005.07.010
P577
2005-10-17T00:00:00Z